| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.003 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.094 | 0.004 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.097 | 0.005 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |